- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
PMCPA reviewed an alleged failure to post EUCTR results for one Novo Nordisk trial flagged by a BMJ audit. Trial was withdrawn…
PMCPA case AUTH/3092/9/18 (Director v Celgene) concerned clinical trial disclosure. The matter was ruled outwith the scope of the ABPI Code (2016).…
PMCPA case AUTH/3072/9/18 (Director v Servier) concerned clinical trial disclosure but was ruled outwith the scope of the ABPI Code (2016). No…
Anonymous ex-employee alleged medical oncology staff were pressured to generate proactive contacts, promote unlicensed medicines, exceed call limits and solicit NICE challenge…
A prescribing advisor challenged Meda’s ‘Case for EpiPen’ booklet as emotive and unsubstantiated. The PMCPA ruled multiple claims misleading/unsubstantiated and one statement…
Bayer self-reported a global-issued Levitra symposium invitation sent to UK delegates without UK certification. It lacked required prescribing/AE info, used an unapproved…
Anonymous complaint said a Xarelto GP ad calling dosing “simple” downplayed anticoagulant risks. PMCPA ruled “simple” referred only to once-daily dosing and…
MSD challenged a Victoza detail aid using a “triple composite endpoint” shown in prominent red boxes. PMCPA ruled the presentation misleading (Clause…
Anonymous NHS HCPs complained about excessive hospitality at an ISU meeting in Belfast. Allergan funded venue/AV via an educational grant. Panel found…
Roche-sponsored AAV workshop was deemed promotional due to slides and signposting to rituximab content, and it implied Mabthera use across all AAV…
Ex-employee alleged excessive sponsorship of 33 UK HCPs to FIGO Rome 2012. Panel reviewed costs (travel, hotel, dinners) under Clause 19.1 and…
A Sanofi representative persuaded an NHS administrator to email a promotional GLP-1 webcast invite to GP practices via NHS.net, without opt-in permission…
Allergan was ruled in breach after a meeting presentation and representative conduct implied Vistabel/Botox was more potent than Bocouture/Xeomin, contrary to SPC…
Lilly lung cancer maintenance ad appeared on a US creative media site without a password after an agency award submission. Panel found…
Alexion’s entry in a UK society meeting programme was alleged to promote an unlicensed medicine. Panel noted potentially ambiguous “late-stage therapies” wording…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.